Showing 27,121 - 27,140 results of 226,405 for search '(( a ((((laser decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 2.10s Refine Results
  1. 27121
  2. 27122
  3. 27123
  4. 27124
  5. 27125

    <b>Excessive free fatty acids sensing in pituitary lactotrophs elicits steatotic liver disease by decreasing prolactin levels</b> by Xinlu Ji (12433917)

    Published 2024
    “…Here, we demonstrated that elevated FFAs levels increased the risk of MASLD mediating by decreased prolactin (PRL) levels in a liver biospecimen-based cohort. …”
  6. 27126
  7. 27127
  8. 27128
  9. 27129
  10. 27130
  11. 27131
  12. 27132

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  13. 27133
  14. 27134
  15. 27135
  16. 27136

    Ubiquitin ligases of the rat pineal gland whose expression is decreased by dbcAMP<sup>*</sup> or NE <i>in vitro</i>. by Jerry Vriend (3756514)

    Published 2017
    “…<p>Ubiquitin ligases of the rat pineal gland whose expression is decreased by dbcAMP<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0172441#t005fn001" target="_blank">*</a></sup> or NE <i>in vitro</i>.…”
  17. 27137
  18. 27138
  19. 27139
  20. 27140

    Mendelian randomization estimate of the association of decreased 25OHD with the risk of multiple sclerosis excluding the <i>DHCR7</i> locus. by Lauren E. Mokry (787325)

    Published 2015
    “…<p><sup>a</sup>OR is expressed as the odds of MS for a 1-SD decrease in natural-log-transformed 25OHD level.…”